GF Giskeødegård, H Bertilsson, KM Selnæs, AJ Wright… - PloS one, 2013 - journals.plos.org
Separating indolent from aggressive prostate cancer is an important clinical challenge for
identifying patients eligible for active surveillance, thereby reducing the risk of overtreatment …